Essalia
A More Considered Approach to Skin Quality.
A processed human dermal-matrix injectable discussed for selected dermal quality concerns, with careful attention to product identity and tissue safety.
Type
Human acellular dermal matrix (hADM), pink 1.0 cc presentation
Main Focus
Selected skin quality and structural environment
Duration
Confirmed after assessment
Course
Only after local label and IFU verification
What It Is
Essalia is presented as injectable processed human acellular dermal matrix (hADM), supplied in the pink 1.0 cc presentation used by our clinic.
Main Use
A doctor may assess dermal roughness and quality, but the specific benefit of this product remains to be established in independent trials.
Main Benefits
Some human studies investigate other injectable ADM products, but those findings cannot automatically be applied to Essalia specifically.
How It Works
hADM is processed tissue-derived matrix material, differing from conventional HA fillers which use manufactured gel to add hydration or structure. A related product is described elsewhere as 3% micronised hADM; the exact mapping to this presentation must be verified against the supplied label.
Who It Suits
Patients who understand the human-tissue origin, potential limitations and procedural risks, after the doctor confirms regulatory and tissue-safety requirements.
Treatment Duration
Confirmed after assessment; a fixed course cannot be responsibly quoted without the exact local product instructions.
Sessions Needed
A fixed course cannot be responsibly quoted without the exact Essalia local instructions and label verification.
Results Timeline
There is insufficient verified Essalia-specific research to give a precise timeline.
Results Longevity
Durability is not yet well defined for the specific presentation shown; a fixed duration would be misleading.
Downtime
Swelling, bruising, pain or injection marks may occur after treatment.
Side Effects
Infection, nodules, inflammatory reactions and injection-related vascular injury are possible; the donor tissue source adds traceability requirements.
Alone Or Combined
Only when distinct concerns support a staged medical plan, not because combination packages are popular.
A processed human dermal-matrix injectable discussed for selected dermal quality concerns, with careful attention to product identity and tissue safety.
Purposeful Combinations
ADVATx Yellow Laser
To address redness or pigment-related concerns separately, after skin recovery.
SylfirmX
Considered for a distinct texture or scar indication, after evaluating tissue response.
Suitable HA filler
For diagnosed volume or structure goals, with separate consent and budget.
Skin analysis / photographs
Establishes a baseline and monitors actual change, rather than relying on subjective glow claims.
Daily SPF and skin care
Supports consistent skin management.
Commonly Asked
Reviewed by Dr. Dinesh Kanasen (MMC 43953) · Last updated 22 October 2026
The right treatment begins with a proper diagnosis.
At Dr.D Signature Clinic, we discuss Essalia only after assessing your skin concern, medical history, product-specific evidence, realistic risks and alternatives. A combination is recommended only when it serves a clear separate goal. Book a skin assessment to build a treatment plan around what your skin actually needs.
Curious if Essalia is right for you?
Every treatment plan starts with a doctor-led assessment of your skin, goals and medical history.